Robert Kirsner, MD
Dermatology · Miami, FLNPI 1518991314
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,087,825 of the $1,416,682 with a category attached, or 76.8%. Kerecis Limited accounts for 78.8% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $1,124,876 and has fallen 94.6% since, to $60,783 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $5132.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$1.1M
- Molnlycke Health Care US, LLC$116K
- Smith+Nephew$80K
- Pfizer$29K
- Organogenesis Inc.$16K
- Urgo Medical North America, LLC$15K
- plus $45K from 25 others
Across 61 payments — averaging $2570.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$124K
- Regeneron$12K
- Boehringer Ingelheim International GmbH$10K
- Pfizer$6K
- Biotissue Holdings Inc.$4K
- Medline Industries LP$1K
- plus $87 from 1 others
What the payments were for
- Consulting fees$255,72318%
- Speaking & faculty fees$29,0072%
- Grants$2,5000%
- Travel & lodging$33,8972%
- Food & beverage$7,7161%
- Education$140%
- Other$1,087,82577%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 6 | $1,115,946 |
| Molnlycke Health Care US, LLC | 76 | $116,008 |
| Smith+Nephew | 43 | $79,785 |
| Pfizer | 18 | $29,407 |
| Organogenesis Inc. | 7 | $15,779 |
| Urgo Medical North America, LLC | 16 | $15,010 |
| Medline Industries LP | 8 | $10,800 |
| AbbVie | 7 | $10,442 |
| Novartis | 14 | $6,944 |
| Misonix Inc | 4 | $3,500 |
| Almirall LLC | 3 | $3,389 |
| KCI USA, Inc. | 12 | $2,617 |
| Mallinckrodt Hospital Products Inc. | 3 | $2,200 |
| Regeneron Healthcare Solutions, Inc. | 23 | $1,151 |
| Bristol Myers Squibb | 1 | $1,050 |
| Johnson & Johnson | 8 | $562 |
| UCB, Inc. | 5 | $414 |
| Galderma Laboratories, L.p. | 4 | $371 |
| Integra Lifesciences Corporation | 1 | $175 |
| Lilly USA, LLC | 2 | $174 |
| LEO Pharma Inc. | 3 | $166 |
| Convatec Inc. | 2 | $160 |
| Sun Pharmaceutical Industries Inc. | 2 | $140 |
| Novartis Pharma AG | 1 | $120 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $114 |
| Biotissue Holdings Inc. | 1 | $105 |
| Tactile Systems Technology Inc | 1 | $72 |
| Incyte Corporation | 1 | $41 |
| Bausch Health US, LLC | 1 | $14 |
| OVIK Health, LLC | 1 | $14 |
| Avita Medical Americas, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$3,265,218
- Kerecis Omega3 GraftGuide$1,088,406
- Kerecis Omega3 Marigen$1,088,406
- Kerecis SurgiClose$110,000
- PICO$58,098
- Mepilex Border Flex$42,101
- Exufiber Ag$33,000
- PICO 7$28,554
- PICO 14$27,579
- Kerecis GraftGuide$27,500
- Exufiber$27,000
- ALLEVYN GENTLE 10CM x 10CM (4x4)CTN 10$25,679
- EUCRISA$24,110
- Allevyn Gentle Border 10 x 10cm Ctn 10$24,036
- Mepilex Border Sacrum$21,101
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$14,780
- Molnlycke fluidized positioner$13,500
- Apligraf$12,025
- Mepilex Border Post Op AG$12,000
- Molnlycke tortoise T&P system$10,500
How this compares
$1,416,682 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 20 | $434,797 |
| Dupixent SyringeDupilumab | 38 | $142,779 |
| Dupixent PenDupilumab | 21 | $85,269 |
| Enbrel SureclickEtanercept | 11 | $70,749 |
| Bexarotene | 12 | $35,712 |
| Cyclosporine | 12 | $12,752 |
| Acitretin | 45 | $5,605 |
| Tacrolimus | 23 | $4,636 |
| Cyclosporine ModifiedCyclosporine, Modified | 28 | $3,845 |
| Clobetasol Propionate | 69 | $3,093 |
| Pregabalin | 65 | $1,816 |
| Triamcinolone Acetonide | 118 | $1,741 |
| Pentoxifylline | 31 | $1,475 |
| Metronidazole | 25 | $1,286 |
| Ketoconazole | 97 | $1,254 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Miami
- Francisco KerdelMiami$2.1M
- Gil YosipovitchMiami$1M
- Mercedes GonzalezMiami$943K
- Heather Woolery LloydMiami$609K
- Hadar Lev-TovMiami$326K
- Lawrence SchachnerMiami$309K
- Giovanna CioccaMiami$222K
- Janice Lima MaribonaMiami$217K
- Jill WaibelMiami$116K
- Ana DuarteMiami$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.